.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
To improve healthcare accessibility, the Maharashtra state health department will soon expand MPJAY cancer treatment. Consequently, the government will include advanced therapies and diagnostic tools in the Mahatma Jyotiba Phule Jan Arogya Yojana. Specifically, State Health Minister Prakash Abitkar announced this decision during a high-level meeting in Mumbai. Therefore, this policy change will greatly benefit thousands of patients across the state.
Additionally, the health department aims to strengthen the state's clinical infrastructure. Currently, nine cancer day care or ambulatory centres are operational in Maharashtra. However, the health department plans to establish 27 more such centres in the near future. Minister Abitkar emphasized that robust coordination between the public and private sectors is essential. Moreover, this partnership will help the state combat the rising number of cancer cases. For screening purposes, the health department currently runs one diagnostic van in each of the state's eight administrative circles. As a result, healthcare workers have successfully screened over three crore citizens so far.
Furthermore, the state will introduce cutting-edge clinical options under the revised scheme. Patients will soon receive advanced immunotherapy, which enhances the body's natural defenses to destroy cancer cells. In addition, the scheme will cover highly precise diagnostic tools like positron emission tomography (PET) scans. Previously, patients had to bear these high-end diagnostic costs out of their own pockets. Consequently, including these services will significantly ease the financial burden on families. In the meantime, the Maharashtra Cancer Warriors initiative continues to deliver vital oncology services. Expert oncologists voluntarily support this initiative to provide diagnostic and therapeutic help to patients.
During the high-level meeting, representatives from a South Korean institute presented a lecture on liquid biopsy technology. This revolutionary method allows doctors to detect all types of cancer at a very early stage. Thus, adopting such technology could transform oncology screening and diagnosis in India. Ultimately, early detection remains the most effective tool to improve cancer survival rates. Consequently, health authorities are actively reviewing this technology to assess its implementation viability across public clinics.
Q1: What new cancer treatments and diagnostics will MPJAY include?
The state health department is including advanced immunotherapy and PET scans under the Mahatma Jyotiba Phule Jan Arogya Yojana (MPJAY) to provide modern, comprehensive cancer care.
Q2: How many new ambulatory cancer care centres will Maharashtra establish?
The state plans to add 27 new ambulatory cancer day care centres. These will join the nine currently operational centres to expand regional cancer care access.
Q3: What is the purpose of the Maharashtra Cancer Warriors initiative?
The Maharashtra Cancer Warriors initiative provides expert oncological screening, diagnosis, and treatment services to patients, helping tackle the rising burden of cancer.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Maharashtra health department expands MPJAY to include cancer immunotherapy and PET scans, alongside 27 new ambulatory cancer care centres across the state....
3 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
